EDITORIAL
Specialization improves rectal cancer management: humans not machines determine optimal outcome
Brendan John Moran,
Soren Laurberg,
Corresponding Author
Brendan John Moran
Colorectal Department, Basingstoke Hospital, North Hampshire Foundation Trust, Basingstoke, UK
Correspondence
Brendan John Moran, Colorectal Department, Basingstoke Hospital, North Hampshire Foundation Trust, Aldermaston Road, Basingstoke, RG24 9NA, UK.
Email: [email protected]
Search for more papers by this authorBrendan John Moran,
Soren Laurberg,
Corresponding Author
Brendan John Moran
Colorectal Department, Basingstoke Hospital, North Hampshire Foundation Trust, Basingstoke, UK
Correspondence
Brendan John Moran, Colorectal Department, Basingstoke Hospital, North Hampshire Foundation Trust, Aldermaston Road, Basingstoke, RG24 9NA, UK.
Email: [email protected]
Search for more papers by this authorFirst published: 29 March 2024
No abstract is available for this article.
REFERENCES
- 1Moran BJ. Surgical precision is pivotal and ‘decisions are more important than incisions’: two decades of pelican cancer face to face workshops. Colorectal Dis. 2021; 23: 1192–1197.
- 2Heald RJ, Husband EM, Ryall RD. The mesorectum in rectal cancer surgery—the clue to pelvic recurrence? Br J Surg. 1982; 69: 613–616.
- 3Engeland A, Haldorsen T, Dickman PW, Hakulinen T, Möller TR, Storm HH, et al. Relative survival of cancer patients—a comparison between Denmark and the other Nordic countries. Acta Oncol. 1998; 37(1): 49–50.
- 4Bregendahl S, Bondeven P, Grønborg TK, Brown G, Laurberg S, Pedersen BG. Training of radiology specialists in local staging of primary rectal cancer on MRI: a prospective intervention study exploring the impact of various educational elements on the interpretive performance. BMJ Open Quality. 2022; 11:e001716.
- 5Arnold M, Rutherford MJ, Bardot A, Ferlay J, Andersson TML, Myklebust TÅ, et al. Progress in cancer survival, mortality, and incidence in seven high-income countries 1995-2014 (ICBP SURVMARK-2): a population-based study. Lancet Oncol. 2019; 20(11): 1493–1505.
- 6Nors J, Iversen LH, Erichsen R, Gotschalck KA, Andersen CL. Incidence of recurrence and time to recurrence in stage I to III colorectal cancer: a nationwide Danish cohort study. JAMA Oncologia. 2023;e235098, online ahead of print, 10, 54.
- 7Hughes SP, Macintyre I. Surgeon-anatomist to robotic technician? The evolving role of the surgeon over three centuries. JRSM. 2022; 115(2): 460–466.
- 8Moran BJ, Torkington J. The Pelican OReCO (Optimizing Rectal Cancer Outcomes) Program: in collaboration with ACPGBI: decisions, incisions, technology, Colorectal Dis, accepted for publication.
- 9 https://www.nds.ox.ac.uk/researcg/the-ideal-colloboration
- 10Maxwell-Armstrong C, Cheetham M, Branagan G, Davies J, Davies M, Eardley N, et al. Rectal cancer services—is it time for specialization within units? Colorectal Dis. 2023; 25: 1332–1335.
- 11Cercek A, Lumish N, Sinopoli J, Weiss J, Shia J, Lamendola-Essel M, et al. PD1 blockade in mismatch-repair deficient locally advanced rectal cancer. NEJM. 2022; 386(25): 2363–2376.
- 12Henriksen TV, Demuth C, Frydendahl A, Nors J, Nesic M, Rasmussen MH, et al. Unravelling the potential clinical utility of circulating tumor DNA in colorectal cancer-evaluation in a nationwide Danish cohort. Ann Oncol. 2024; 35: 229–239.
- 13Christensen P, Im Baeten C, Espin-Basany E, Martellucci J, Nugent KP, Zerbib F, et al. Management guidelines for low anterior resection syndrome—the MANUEL project. Colorectal Dis. 2021; 23: 461–465.
